CIK: 0001816307 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $457,181 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 400,014 | $31,313 | 6.8% | $69.81 | +33.8% | COM | 670703107 |
| — | MERUS N V | 680,845 | $28,630 | 6.3% | $26.50 | — | COM | N5749R100 |
| INSM | INSMED INC | 372,230 | $25,699 | 5.6% | $56.86 | +26.7% | COM PAR $.01 | 457669307 |
| — | VERONA PHARMA PLC | 516,014 | $23,964 | 5.2% | $26.48 | — | SPONSORED ADS | 925050106 |
| — | AKERO THERAPEUTICS INC | 739,563 | $20,575 | 4.5% | $24.40 | — | COM | 00973Y108 |
| VCYT | VERACYTE INC | 503,281 | $19,930 | 4.4% | $29.28 | +29.3% | COM | 92337F107 |
| ERAS | ERASCA INC | 7,543,901 | $18,935 | 4.1% | $2.20 | +24.6% | COM | 29479A108 |
| PLRX | PLIANT THERAPEUTICS INC | 1,315,601 | $17,326 | 3.8% | $13.65 | 0.0% | COM | 729139105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,230,400 | $16,266 | 3.6% | $18.29 | -6.4% | COM | 87164F105 |
| RNAM | AVIDITY BIOSCIENCES INC | 543,651 | $15,809 | 3.5% | $19.57 | +113.6% | COM | 05370A108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 273,896 | $15,333 | 3.4% | $30.71 | +79.9% | COM | 76243J105 |
| — | INTRA-CELLULAR THERAPIES INC | 179,085 | $14,957 | 3.3% | $67.09 | — | COM | 46116X101 |
| URGN | UROGEN PHARMA LTD | 1,120,473 | $11,933 | 2.6% | $14.43 | -17.0% | COM | M96088105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 598,952 | $10,032 | 2.2% | $15.99 | — | SPONSORED ADS | 152309100 |
| KOD | KODIAK SCIENCES INC | 1,000,000 | $9,950 | 2.2% | $4.77 | +20.5% | COM | 50015M109 |
| — | POSEIDA THERAPEUTICS INC | 1,012,307 | $9,718 | 2.1% | $3.29 | — | COM | 73730P108 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,178,300 | $9,509 | 2.1% | $4.73 | +94.1% | COM | 68622P109 |
| TELA | TELA BIO INC | 3,065,649 | $9,258 | 2.0% | $4.46 | -37.0% | COM | 872381108 |
| SRRK | SCHOLAR ROCK HLDG CORP | 183,243 | $7,920 | 1.7% | $32.56 | 0.0% | COM | 80706P103 |
| WVE | WAVE LIFE SCIENCES LTD | 608,897 | $7,532 | 1.6% | $5.21 | +156.1% | SHS | Y95308105 |
| COGT | COGENT BIOSCIENCES INC | 921,137 | $7,185 | 1.6% | $9.55 | +4.4% | COM | 19240Q201 |
| ASND | ASCENDIS PHARMA A/S | 51,491 | $7,089 | 1.6% | $138.80 | — | SPONSORED ADR | 04351P101 |
| IRON | DISC MEDICINE INC | 110,381 | $6,998 | 1.5% | $35.70 | +62.0% | COM | 254604101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 264,560 | $6,685 | 1.5% | $30.21 | -10.1% | COM NEW | 15117B202 |
| ELUT | ELUTIA INC | 1,782,271 | $6,666 | 1.5% | $3.32 | +16.8% | CL A COM | 05479K106 |
| — | BIODESIX INC | 4,332,281 | $6,628 | 1.4% | $1.63 | — | COM | 09075X108 |
| — | AKERO THERAPEUTICS INC | 220,000 | $6,120 | 1.3% | — | — | Call | 00973Y908 |
| GOSS | GOSSAMER BIO INC | 6,171,847 | $5,583 | 1.2% | $1.12 | -23.7% | COM | 38341P102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 72,516 | $5,581 | 1.2% | $22.11 | +227.3% | COM NEW | 74006W207 |
| BBOT | HELIX ACQUISITION CORP II | 513,369 | $5,390 | 1.2% | $10.35 | +1.5% | CL A ORD SHS | G4444H101 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 124,388 | $5,233 | 1.1% | $49.61 | 0.0% | COM | 90400D108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 612,173 | $5,185 | 1.1% | $12.06 | -14.1% | COM | 483497103 |
| TVTX | TRAVERE THERAPEUTICS INC | 277,365 | $4,832 | 1.1% | $17.69 | 0.0% | COM | 89422G107 |
| CCCC | C4 THERAPEUTICS INC | 1,221,131 | $4,396 | 1.0% | $7.58 | -34.4% | COM STK | 12529R107 |
| GPCR | STRUCTURE THERAPEUTICS INC | 152,395 | $4,133 | 0.9% | $32.98 | — | SPONSORED ADS | 86366E106 |
| TARS | TARSUS PHARMACEUTICALS INC | 65,955 | $3,652 | 0.8% | $38.27 | +18.7% | COM | 87650L103 |
| INCY | INCYTE CORP | 49,000 | $3,384 | 0.7% | $71.25 | 0.0% | COM | 45337C102 |
| PCVX | VAXCYTE INC | 40,788 | $3,339 | 0.7% | $89.21 | +11.3% | COM | 92243G108 |
| GERN | GERON CORP | 920,022 | $3,257 | 0.7% | $3.96 | +1.0% | COM | 374163103 |
| TRVI | TREVI THERAPEUTICS INC | 734,234 | $3,025 | 0.7% | $3.14 | +2.0% | COM | 89532M101 |
| CGEN | COMPUGEN LTD | 1,624,377 | $2,485 | 0.5% | $1.36 | +19.6% | ORD | M25722105 |
| CERS | CERUS CORP | 1,587,228 | $2,444 | 0.5% | $4.54 | -62.1% | COM | 157085101 |
| — | SYNDAX PHARMACEUTICALS INC | 172,400 | $2,279 | 0.5% | — | — | Call | 87164F905 |
| ABVX | ABIVAX SA | 285,120 | $2,087 | 0.5% | $13.37 | — | SPONSORED ADS | 00370M103 |
| — | UNICYCIVE THERAPEUTICS INC | 2,486,709 | $1,975 | 0.4% | $0.41 | — | COM | 90466Y103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 100,000 | $1,917 | 0.4% | $21.74 | 0.0% | COM | 92790C104 |
| DCTH | DELCATH SYS INC | 155,325 | $1,870 | 0.4% | $10.55 | 0.0% | COM NEW | 24661P807 |
| QURE | UNIQURE NV | 100,000 | $1,766 | 0.4% | $8.63 | 0.0% | SHS | N90064101 |
| MODD | MODULAR MED INC | 1,272,015 | $1,743 | 0.4% | $1.79 | +7.7% | COM NEW | 60785L207 |
| KALA | KALA BIO INC | 231,070 | $1,604 | 0.4% | $6.30 | 0.0% | COM NEW | 483119202 |
| — | NEUMORA THERAPEUTICS INC. | 147,200 | $1,560 | 0.3% | — | — | Call | 640979900 |
| OLMA | OLEMA PHARMACEUTICALS INC | 233,281 | $1,360 | 0.3% | $8.45 | +18.2% | COM | 68062P106 |
| GILD | GILEAD SCIENCES INC | 10,000 | $924 | 0.2% | $87.00 | 0.0% | COM | 375558103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 121,274 | $903 | 0.2% | $22.05 | -57.8% | COM NEW | 30233G209 |
| RADX | RADIOPHARM THERANOSTICS LTD | 187,406 | $841 | 0.2% | $4.49 | — | SPONSORED ADS | 75041J101 |
| — | 89BIO INC | 96,511 | $755 | 0.2% | $12.50 | — | COM | 282559103 |
| VXRT | VAXART INC | 1,077,782 | $714 | 0.2% | $0.76 | -8.6% | COM NEW | 92243A200 |
| — | KARYOPHARM THERAPEUTICS INC | 595,990 | $403 | 0.1% | $3.50 | — | COM | 48576U106 |
| GUTS | FRACTYL HEALTH INC | 176,922 | $364 | 0.1% | $8.07 | -71.1% | COM | 35168W103 |
| BIOA | BIOAGE LABS INC | 39,974 | $231 | 0.1% | $20.04 | -13.9% | COM | 09077V100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 104,828 | $4 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |